Government confirms underwater oil plumes – WWL First News

The government says water tests have confirmed underwater oil plumes from the BP oil spill, but that concentrations are “very low.” NOAA Administrator Jane Lubchenco said that the tests conducted at three sites by a University of South Florida

Wall Street Media Presents Eric Whitman, MD on Delcath’s Positive Clinical Results – Yahoo Finance
Delcath’s PHP clinical trials have focused on a certain melanoma spread to the liver. Some key factors we think were overlooked or misunderstood in today’s market action are: Survival rate tripled for cancer patients treated with PHP (Percutaneous Hepatic Perfusion) – 398 days vs. 124 with best

Bing Search Library for PHP Now Available – Softpedia
A new open source project available from Microsoft is designed to simplify the work for PHP developers looking to leverage Bing search results in their applications. The Bing Search Library for PHP is now available for download from the Redmond

PHP Development India,PHP Application Development,PHP Programming PHP – PRLog (free press release)
the early adopters of some of the open source processes which have become standards today. We have a sizeable team of PHP developers, which is well-versed in Linux Apache MySQL PHP (LAMP) & AJAX. You can hire PHP and MySQL developers from us for all

Wall Street Media Presents Eric Whitman, MD on Delcath – PR Inside
Society of Clinical Oncology’s (ASCO hepatic PFS (primary endpoint) was 245 days in the PHP arm and 49 days in the BAC (best alternative care) arm – $745 million is the estimate for peak annual U.S. sales, if PHP is approved by the FDA -

Delcath Systems (DCTH) Presents Phase III Data Comparing PHP with Melphalan to the Best Treatments Available – StreetInsider.com
Delcath Systems, Inc. (Nasdaq: DCTH ) highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology’s 2010 Annual Meeting, comparing percutaneous hepatic perfusion (PHP) with melphalan to the best alternative care for patients with hepatic metastases from

Delcath Systems (DCTH) Presents Phase III Data – StreetInsider.com
Delcath Systems, Inc. (Nasdaq: DCTH ) highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology’s 2010 Annual Meeting, comparing percutaneous hepatic perfusion (PHP) with melphalan to the best alternative